Example: tourism industry

Zejula (niraparib) capsules - GSKpro

• Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML): were fatal. Monitor patients for hematological toxicity and discontinue if MDS/AML is confirmed. (5.1) • Bone Marrow Suppression: Test complete blood counts weekly for the first month, monthly for the next 11 months, and periodically thereafter for clinically significant changes.

Tags:

  Acute, Leukemia, Myeloid, Acute myeloid leukemia, Niraparib

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries